Phosphodiesterase-5 Inhibitors Could Be Efficacious in the Treatment of Erectile Dysfunction after Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis

Publisher： Karger

E-ISSN： 1423-0399|90|3|339-347

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.90, Iss.3, 2012-12, pp. : 339-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effectiveness of Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction in Patients with Spinal Cord Trauma: Systematic Review and Meta-Analysis

By  

Urologia Internationalis, Vol. 98, Iss. 2, 2016-08 ,pp. : 198-204

Karger

Access to resources Recommend Favorite

Tadalafil 5 mg Once Daily Improves Lower Urinary Tract Symptoms and Erectile Dysfunction: A Systematic Review and Meta‐analysis

By  

LUTS, Vol. 10, Iss. 1, 2018-01 ,pp. : 84-92

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk–benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 4, 2015-04 ,pp. : 436-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Update on the Use of Phosphodiesterase Inhibitors in the Treatment of Erectile Dysfunction

By  

Current Urology, Vol. 2, Iss. 3, 2009-01 ,pp. : 113-121

Karger

Access to resources Recommend Favorite

Decision aids for localized prostate cancer treatment choice: Systematic review and meta‐analysis

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 3, 2015-05 ,pp. : 239-251

John Wiley & Sons Inc

Access to resources Recommend Favorite